GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the M.TUBERCULOSIS mbct-mbca toxin-antitoxin complex.

Analyse Crystal structure of the M.TUBERCULOSIS mbct-mbca toxin-antitoxin complex. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FKG
Type
protein
Length
587 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P9WLP9, P9WLP7

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein182—P9WLP9
B—protein183—P9WLP9
C, D—protein111—P9WLP7

Ligands and binding sites

  • GOL · Glycerol · additive · 3 copies · chains B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6FKG · Crystal structure of the M.tuberculosis MbcT-MbcA toxin-antitoxin complex. · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WLP9 · AlphaFold monomer V2.0 prediction for NAD(+) phosphorylase mbct (P9WLP9) · a predicted model of the same protein · chain B against A, TM-score 0.97
  • P9WLP7 · AlphaFold monomer V2.0 prediction for mycobacterial cidal antitoxin mbca (P9WLP7) · a predicted model of the same protein · chain C against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.